San Diego, CA – A promising treatment for patients with spinal cord injuries and a therapy aimed at helping HIV patients create an AIDS-resistant blood system were approved today by the state’s stem ...

Our candidate product PSCA-CAR_s15 uiNK is derived from transduction of iPSCs selected from the most ideal source and episomally reprogrammed from mature NK cells or CD34+ cells. Our goal is to ...

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

The statewide network is designed to overcome manufacturing bottlenecks that have delayed or stalled development and approval of regenerative medicines. “These awards are a critical first step in ...

Title 17 California Code of Regulations Section 100080(f) designates all human pluripotent stem cell lines derived in accordance with the CIRM regulations as “acceptably derived.” These cell lines may ...

Objetivo de la investigación Los objetivos de la investigación son identificar los genes causales de la toxicidad mitocondrial y la neurodegeneración inducidas por la quimioterapia en las neuronas ...

CIRM is an Agency of partnerships and collaboration. Its team of dedicated professionals work together to advance innovative science and accelerate treatments to deliver on its mission. By fostering ...

In addition to providing funding for regenerative medical research, CIRM offers a rich array of other resources designed to support and accelerate individual projects. In doing so, CIRM fosters ...

Learn more about CIRM’s dedicated board members, how they’re appointed, and the regulations that guide their work. Subcommittees and task forces are comprised solely of board members. They help the ...

在多发性骨髓瘤中，炎症和抗病毒途径促进疾病进展和癌症干细胞生成。使用不同的临床前模型，我们研究了干扰素调节因子 4 (IRF4) 在骨髓瘤祖细胞再生中的作用。在一个重现人骨髓瘤中 IRF4 ...

Click on the appropriate link and follow the posted instructions. Proposal templates can be located and submitted under the “Uploads” section. 4. To submit your Application Click on the “Done with ...